SCHEMBL9565282

SCHEMBL9565282

CCCCCCC/C=C/CC(O)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 2/20 0.58
▸ FFAR4 Q5NUL3 1/20 0.58
▸ TERT O14746 3/20 0.56
▸ PTPN1 P18031 3/20 0.56
▸ PPARG P37231 3/20 0.56
▸ PPARD Q03181 3/20 0.56
▸ PPARA Q07869 3/20 0.56
▸ TOP1 P11387 3/20 0.56
▸ MAPT P10636 2/20 0.56
▸ BLM P54132 2/20 0.56
▸ HSD17B10 Q99714 2/20 0.56
▸ FABP4 P15090 2/20 0.56
▸ GMNN O75496 1/20 0.56
▸ USP2 O75604 1/20 0.56
▸ LMNA P02545 1/20 0.56
▸ CYP1A2 P05177 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ CYP2C9 P11712 1/20 0.56
▸ ALOX15 P16050 1/20 0.56
▸ APEX1 P27695 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9565350 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577761 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577706 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577954 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577707 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9565349 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577957 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577934 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577652 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG
SCHEMBL9577643 1.00 FFAR1 (0.58) FFAR1FFAR4TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0568307-A1 Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives UNILEVER PLC (GB) 1993-11-03 — — EP claimed
US-5108751-A COSMETIC COMPOSITION COMPRISING 2-HYDROXYALKENOIC ACIDS OR A MIXTURE THEREOF CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1992-04-28 — — US claimed
EP-0442708-A2 Cosmetic composition UNILEVER PLC (GB) 1991-08-21 — — EP claimed
US-12082582-B2 Synergistic preservative compositions, process for preparing the same and method of use thereof ISP INVESTMENTS LLC (US) 2024-09-10 — — US disclosed
CN-113301802-B Synergistic preservative compositions, methods of making and methods of use thereof ISP投资有限公司 2023-08-25 — — CN disclosed
CN-107613767-B Synergistic preservative composition ISP投资有限公司 2022-06-21 — — CN disclosed
US-20220030862-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF ISP INVESTMENTS LLC (US) 2022-02-03 — — US disclosed
CN-113301802-A Synergistic preservative compositions, methods of making and methods of using the same ISP投资有限公司 2021-08-24 — — CN disclosed
US-20180092357-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP INVESTMENTS LLC (US) 2018-04-05 — — US disclosed
EP-3288380-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP Investments LLC (US) 2018-03-07 — — EP disclosed
WO-2016164555-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS ISP INVESTMENTS INC. (US) 2016-10-13 — — WO disclosed
EP-0568307-A1 Cosmetic composition containing alpha hydroxy carboxylic acids as preservatives UNILEVER PLC (GB) 1993-11-03 — — EP disclosed
US-5227503-A 2-Hydroxyalkenoic acids CHESEBROUGH POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1993-07-13 — — US disclosed
US-5108751-A COSMETIC COMPOSITION COMPRISING 2-HYDROXYALKENOIC ACIDS OR A MIXTURE THEREOF CHESEBROUGH-POND'S USA CO., DIVISION OF CONOPCO, INC. (US) 1992-04-28 — — US disclosed
EP-0442708-A2 Cosmetic composition UNILEVER PLC (GB) 1991-08-21 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12082582-B2 Synergistic preservative compositions, process for preparing the same and method of use thereof HPD, EBP, TET1 FFAR1 942/4885FFAR4 1865/4885TERT 1531/4885
US-20180092357-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS PIEZO1, CASP1, PRNP FFAR1 2974/4885FFAR4 3945/4885TERT 1259/4885
US-20220030862-A1 SYNERGISTIC PRESERVATIVE COMPOSITIONS, PROCESS FOR PREPARING THE SAME AND METHOD OF USE THEREOF HPD, EBP, TET1 FFAR1 942/4885FFAR4 1865/4885TERT 1531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback